Related Experiment Video
Updated: Mar 16, 2026
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Diagnosis and Molecular Classification of Lung Cancer
Jaime Rodriguez-Canales1, Edwin Parra-Cuentas1, Ignacio I Wistuba2
1Department of Translational Molecular Pathology, Unit 951, The University of Texas MD Anderson Cancer Center, 2130 Holcombe Blvd., Houston, TX, 77030, USA.
Abstract:
Lung cancer is a complex disease composed of diverse histological and molecular types with clinical relevance. The advent of large-scale molecular profiling has been helpful to identify novel molecular targets that can be applied to the treatment of particular lung cancer patients and has helped to reshape the pathological classification of lung cancer. Novel directions include the immunotherapy revolution, which has opened the door for new opportunities for cancer therapy and is also redefining the classification of multiple tumors, including lung cancer. In the present chapter, we will review the main current basis of the pathological diagnosis and classification of lung cancer incorporating the histopathological and molecular dimensions of the disease.
Insights
This review covers lung cancer diagnosis and classification, integrating histopathology and molecular data. Advances in molecular profiling and immunotherapy are reshaping treatment strategies for lung cancer patients.
Area of Science:
- Oncology
- Pathology
- Genomics
Background:
- Lung cancer presents diverse histological and molecular subtypes impacting clinical outcomes.
- Molecular profiling has identified new therapeutic targets, influencing lung cancer classification.
- Immunotherapy advancements are revolutionizing cancer treatment and redefining tumor classification.
Purpose of the Study:
- To review the current pathological diagnosis and classification of lung cancer.
- To integrate histopathological and molecular aspects of lung cancer.
- To highlight the impact of molecular profiling and immunotherapy on lung cancer classification.
Main Methods:
- Review of current literature on lung cancer pathology.
- Analysis of molecular profiling data in lung cancer.
- Integration of histopathological and molecular findings.
Main Results:
- Lung cancer classification is evolving with molecular and histopathological data.
- Molecular targets are crucial for personalized lung cancer treatment.
- Immunotherapy is a significant factor in modern lung cancer classification and therapy.
Conclusions:
- Accurate lung cancer diagnosis relies on integrating histopathological and molecular features.
- Personalized medicine in lung cancer is driven by molecular insights.
- The classification of lung cancer continues to evolve with therapeutic advancements.
